"","V1","V2","V3","V4","V5","V6","V7","V8","V9","V10","V11","V12","V13","V14","V15","V16","V17","V18","V19","V20","V21","V22","V23","V24","V25","V26","V27","V28","V29","V30","V31","V32","V33","V34","V35","V36","V37","V38","V39","V40","V41","V42","V43","V44","V45","V46","V47","V48","V49","V50","V51","V52","V53","V54","V55","V56","V57","V58","V59","V60","V61","V62","V63","V64","V65","V66","V67","V68","V69","V70","V71","V72","V73","V74","V75","V76","V77","V78","V79","V80","V81","V82","V83","V84","V85","V86","V87","V88","V89","V90","V91","V92","V93","V94","V95","V96","V97","V98","V99","V100","V101","V102","V103","V104","V105","V106","V107","V108","V109","V110","V111","V112","V113","V114","V115","V116","V117","V118","V119","V120","V121","V122","V123","V124","V125","V126","V127","V128","V129","V130","V131","V132","V133","V134","V135","V136","V137","V138","V139","V140","V141","V142","V143","V144","V145","V146","V147","V148","V149","V150","V151","V152","V153","V154","V155"
"1","abs61.txt","a","major","challenge","associated","with","biochemical","and","cellular","analysis","ofpseudokinases","is","lack","of","target-validated","small-molecule","compounds","whichto","probe","function","","tribbles","2","(trib2)","cancer-associated","pseudokinase","adiverse","interactome","including","the","canonical","akt","signaling","module","there","issubstantial","evidence","that","human","trib2","promotes","survival","drug","resistance","insolid","tumors","blood","cancers","therefore","interest","as","therapeutictarget","unusual","domain","contains","unique","cysteine-richc-helix","interacts","conserved","peptide","motif","in","its","own","carboxyl-terminaltail","which","also","supports","interaction","e3","ubiquitin","ligases","we","foundthat","target","previously","described","protein","kinaseinhibitors","were","originally","designed","to","inhibit","kinasedomains","epidermal","growth","factor","receptor","tyrosine","kinase","family","members","usinga","thermal","shift","assay","discovered","trib2-binding","within","publishedkinase","inhibitor","set","(pkis)","used","repurposing","approach","classifycompounds","either","stabilized","or","destabilized","vitro","trib2destabilizing","agents","covalent","afatinib","led","rapid","trib2degradation","aml","cancer","cells","eliciting","tractable","effects","on","signalingand","our","data","reveal","new","leads","for","development","oftrib2-degrading","will","be","invaluable","unraveling","thecellular","mechanisms","trib2-based","study","highlights","smallmolecule-induced","down-regulation","through","off-targets","might","berelevant","other","inhibitors","serendipitously","pseudokinases"
